Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Emergent BioSolutions begins trial of TRU-016 in relapsed, indolent lymphoma

Aug. 18, 2011

Clavis reports interim results from phase II trial of elacytarabine/idarubicin combination

Aug. 17, 2011

Genetically altered T cells eradicate chronic lymphocytic leukemia cells in patients

Aug. 17, 2011

Acetylon Pharmaceuticals prepares novel HD6 inhibitors

Aug. 17, 2011

New agent exploits Warburg effect and shows promise in renal cell cancer models

Aug. 17, 2011

Chugai obtains exclusive Japanese rights to vemurafenib

Aug. 16, 2011

TapImmune and Mayo Clinic to conduct phase I trial of breast cancer vaccine

Aug. 16, 2011

Senesco Technologies begins phase Ib/IIa SNS01-T trial

Aug. 16, 2011

Mologen provides update on ongoing trials of anticancer candidates

Aug. 16, 2011

Bio-Path completes treatment of first cohort of phase I BP-100-1.01 trial

Aug. 16, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...